Cortisone & Fatty Liver Disease
Cortisone is a medication that replicates the effects of some hormones in your body known as corticosteroids. Your levels of these hormones affect your tissues in many ways. Too much cortisone may contribute to a condition known as “metabolic syndrome,” a problem that can cause fat to accumulate in your liver, among other effects.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
What is Cortisone?
Cortisone is a synthetic corticosteroid hormone that resembles the naturally produced hormone cortisol. Cortisol has an anti-inflammatory effect on the body, so your doctor may prescribe cortisone if you have health problems that are a result of too much inflammation, such as:
- arthritis lupus
- psoriasis
- ulcerative colitis
- some autoimmune conditions
Cortisone can also weaken your immune system, cause your skin to become thin and fragile and can also lead to a condition known as Cushing syndrome, which is a result of elevated corticosteroid levels.
Fatty Liver
Side Effects of Dianabol
Learn More
Fatty liver disease, also known as steatohepatitis, is a health problem caused by fat accumulating in your liver. Although many cases of fatty liver disease are caused by alcohol consumption, you can also develop a fatty liver in the absence of excessive alcohol consumption. Although fatty liver itself does not usually cause any symptoms, it can cause inflammation of your liver, ultimately resulting in permanent liver damage and scarring.
Cortisone and Fatty Liver
Consuming cortisone, particularly if you are taking high doses, can result in the development of fatty liver disease. High levels of cortisol can disrupt your body’s metabolic pathways and result in fat becoming deposited in the liver. Elevated cortisol levels can also lead to high levels of triglycerides in the blood and may also make the body resistant to insulin, further disrupting the body’s metabolism; this is also known as metabolic syndrome. Because cortisone affects the body in the same ways as endogenously produced cortisol, taking cortisone can potentially lead to fatty liver disease 2.
- Consuming cortisone, particularly if you are taking high doses, can result in the development of fatty liver disease.
- Elevated cortisol levels can also lead to high levels of triglycerides in the blood and may also make the body resistant to insulin, further disrupting the body’s metabolism; this is also known as metabolic syndrome.
Prevention
Leucine Overdose
Learn More
Taking cortisone is a mainstay of the treatments for many diseases, despite its potentially serious side effects. If you must take cortisone or other synthetic corticosteroids to manage a health problem and are concerned about side effects, talk to your doctor about trying a lower dose. You can also reduce your risk of side effects by using shorter-acting corticosteroids or by avoiding taking corticosteroids orally, because ingesting corticosteroids causes an increase in their levels throughout the body, which is associated with a greater risk of side effects.
Related Articles
References
- Drugs.com; Cortisone; 2010
- Science Daily; Cortisol and Fatty Liver; 2008
- Masala S, Fiori R, Bartolucci DA, et al. Diagnostic and therapeutic joint injections. Semin Intervent Radiol. 2010;27(2):160-71. doi:10.1055/s-0030-1253514
- Mak IYF, Au yeung BYT, Ng YW, et al. Salivary Cortisol and Cortisone After Low-Dose Corticotropin Stimulation in the Diagnosis of Adrenal Insufficiency. J Endocr Soc. 2017;1(2):96-108. doi:10.1210/js.2016-1056
- Nuelle CW, Cook CR, Stoker AM, Cook JL, Sherman SL. In Vivo Toxicity of Local Anesthetics and Corticosteroids on Supraspinatus Tenocyte Cell Viability and Metabolism. Iowa Orthop J. 2018;38:107-112.
- Waterbrook AL, Balcik BJ, Goshinska AJ. Blood Glucose Levels After Local Musculoskeletal Steroid Injections in Patients With Diabetes Mellitus: A Clinical Review. Sports Health. 2017;9(4):372-374. doi:10.1177/1941738117702585
- Gross C, Dhawan A, Harwood D, Gochanour E, Romeo A. Glenohumeral joint injections: a review. Sports Health. 2013;5(2):153-9. doi:10.1177/1941738112459706
- Alsop RJ, Khondker A, Hub JS, Rheinstädter MC. The Lipid Bilayer Provides a Site for Cortisone Crystallization at High Cortisone Concentrations. Sci Rep. 2016;6:22425. doi:10.1038/srep22425
- Holland C, Jaeger L, Smentkowski U, Weber B, Otto C. Septic and aseptic complications of corticosteroid injections: an assessment of 278 cases reviewed by expert commissions and mediation boards from 2005 to 2009. Dtsch Arztebl Int. 2012;109(24):425-30. doi:10.3238/arztebl.2012.0425
- Park SK, Choi YS, Kim HJ. Hypopigmentation and subcutaneous fat, muscle atrophy after local corticosteroid injection. Korean J Anesthesiol. 2013;65(6 Suppl):S59-61. doi:10.4097/kjae.2013.65.6S.S59
- Cheng J, Abdi S. Complications of joint, tendon, and muscle injections. Tech Reg Anesth Pain Manag. 2007;11(3):141-147. doi:10.1053/j.trap.2007.05.006
- Nepple JJ, Matava MJ. Soft tissue injections in the athlete. Sports Health. 2009;1(5):396-404. doi:10.1177/1941738109343159
- Hepper CT, at al. The Efficacy and Duration of Intra-articular Corticosteroid Injection for Knee Osteoarthritis: A Systematic Review of Level I Studies. J Am Acad Orthop Surg. 2009 Oct;17(10):638-46.
- Koester MC, Dunn WR, Kuhn JE, Spindler KP. The Efficacy of Subacromial Corticosteroid Injection in the Treatment of Rotator Cuff Disease: A Systematic Review. J Am Acad Orthop Surg. 2007 Jan;15(1):3-11.
Writer Bio
Adam Cloe has been published in various scientific journals, including the "Journal of Biochemistry." He is currently a pathology resident at the University of Chicago. Cloe holds a Bachelor of Arts in biochemistry from Boston University, a M.D. from the University of Chicago and a Ph.D. in pathology from the University of Chicago.